Medscape asked over 2340 physicians for their opinions about 10 divisive social issues. This article focuses on what your colleague are saying about four particularly contentious topics.
Researchers found that second-line immunosuppression for severe immune-related adverse events was associated with impaired survival outcomes among patients with advanced melanoma.
Findings from a CDC-supported study suggest that updated, bivalent boosters targeting recently circulating Omicron subvariants may benefit adults with immunocompromising conditions.